• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老细胞清除剂通过改善骨形成来控制骨髓间充质干细胞的命运。

Senolytic controls bone marrow mesenchymal stem cells fate improving bone formation.

作者信息

Zhang Dianying, Yu Kai, Yang Jie, Xie Shangding, Yang Jian, Tan Li

机构信息

Department of Orthopedics and Trauma, People's Hospital, Peking University Beijing 100044, China.

Department of Orthopedics, Tianjin Fifth Central Hospital Tianjin 300450, China.

出版信息

Am J Transl Res. 2020 Jun 15;12(6):3078-3088. eCollection 2020.

PMID:32655832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7344065/
Abstract

Bone marrow mesenchymal stem cells (BMSCs) are multipotential stem cells. Osteoporosis is an age-related disorder characterized by increased marrow fat accumulation and declined bone formation. Aging is an important initial factor of bone mass loss. So, manipulating the senescence of BMSCs is a considerable therapeutic target for osteoporosis treatment. To investigate the role of senolytics on regulating the differential fate of senescent BMSCs. Rat BMSCs were isolated and identified by immunofluorescence and multilineage differentiation assay. Quercetin was used to clean senescent BMSCs. Cell counting kit-8 (CCK-8) and colony formation assay was used to evaluate the cellular proliferation. While the cellular migration was detected by the scratch wound healing assay and transwell assay. And the osteogenesis assay and adipogenesis assay were used to determine the differential fate of BMSCs. BMSCs exhibited stemness. Eliminating senescent BMSCs improved the proliferation of BMSCs. But the quercetin treatment made no difference in cellular migration. And the osteogenic potential was increased while the adipogenic potential was decreased when the senescent BMSCs were cleaned by quercetin treatment. Our results demonstrate that cleaning senescent BMSCs improves the proliferation and osteogenesis of BMSCs as well as inhibits the adipogenesis of BMSCs, which provides a novel therapeutic target for the treatment of osteoporosis.

摘要

骨髓间充质干细胞(BMSCs)是多能干细胞。骨质疏松症是一种与年龄相关的疾病,其特征是骨髓脂肪堆积增加和骨形成减少。衰老是骨质流失的一个重要初始因素。因此,调控BMSCs的衰老状态是骨质疏松症治疗中一个值得关注的治疗靶点。为了研究衰老细胞溶解剂对调节衰老BMSCs不同命运的作用。通过免疫荧光和多谱系分化试验分离并鉴定大鼠BMSCs。使用槲皮素清除衰老的BMSCs。采用细胞计数试剂盒-8(CCK-8)和集落形成试验评估细胞增殖。同时,通过划痕伤口愈合试验和Transwell试验检测细胞迁移。并采用成骨试验和脂肪生成试验来确定BMSCs的不同命运。BMSCs表现出干性。清除衰老的BMSCs可改善BMSCs的增殖。但槲皮素处理对细胞迁移没有影响。当用槲皮素处理清除衰老的BMSCs时,成骨潜能增加,而脂肪生成潜能降低。我们的结果表明,清除衰老的BMSCs可改善BMSCs的增殖和成骨能力,并抑制BMSCs的脂肪生成,这为骨质疏松症的治疗提供了一个新的治疗靶点。

相似文献

1
Senolytic controls bone marrow mesenchymal stem cells fate improving bone formation.衰老细胞清除剂通过改善骨形成来控制骨髓间充质干细胞的命运。
Am J Transl Res. 2020 Jun 15;12(6):3078-3088. eCollection 2020.
2
Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis.通过骨靶向递送衰老细胞裂解剂来清除衰老细胞可增加老年性骨质疏松症中的骨形成。
Acta Biomater. 2023 Feb;157:352-366. doi: 10.1016/j.actbio.2022.11.056. Epub 2022 Dec 5.
3
Intraperitoneal injection of Desferal® alleviated the age-related bone loss and senescence of bone marrow stromal cells in rats.腹腔注射去铁胺可减轻大鼠与年龄相关的骨质流失和骨髓基质细胞衰老。
Stem Cell Res Ther. 2021 Jan 7;12(1):45. doi: 10.1186/s13287-020-02112-9.
4
Psoralidin prevents caffeine-induced damage and abnormal differentiation of bone marrow mesenchymal stem cells via the classical estrogen receptor pathway.补骨脂定通过经典雌激素受体途径预防咖啡因诱导的骨髓间充质干细胞损伤和异常分化。
Ann Transl Med. 2021 Aug;9(15):1245. doi: 10.21037/atm-21-3153.
5
Alkbh1-mediated DNA N6-methyladenine modification regulates bone marrow mesenchymal stem cell fate during skeletal aging.Alkbh1 介导的 DNA N6-甲基腺嘌呤修饰调节骨骼衰老过程中骨髓间充质干细胞的命运。
Cell Prolif. 2022 Feb;55(2):e13178. doi: 10.1111/cpr.13178. Epub 2022 Jan 11.
6
MOTS-c improves osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via TGF-β/Smad pathway.MOTS-c 通过 TGF-β/Smad 通路促进骨髓间充质干细胞的成骨分化来改善骨质疏松症。
Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7156-7163. doi: 10.26355/eurrev_201811_16247.
7
Characterization and immunogenicity of bone marrow-derived mesenchymal stem cells under osteoporotic conditions.骨质疏松症条件下骨髓间充质干细胞的特征和免疫原性。
Sci China Life Sci. 2020 Mar;63(3):429-442. doi: 10.1007/s11427-019-1555-9. Epub 2019 Dec 20.
8
Porous Se@SiO nanocomposite promotes migration and osteogenic differentiation of rat bone marrow mesenchymal stem cell to accelerate bone fracture healing in a rat model.多孔 Se@SiO 纳米复合材料促进大鼠骨髓间充质干细胞的迁移和成骨分化,加速大鼠骨折模型中的骨愈合。
Int J Nanomedicine. 2019 May 24;14:3845-3860. doi: 10.2147/IJN.S202741. eCollection 2019.
9
Local Elimination of Senescent Cells Promotes Bone Defect Repair during Aging.衰老细胞的局部清除促进衰老过程中的骨缺损修复。
ACS Appl Mater Interfaces. 2022 Jan 26;14(3):3885-3899. doi: 10.1021/acsami.1c22138. Epub 2022 Jan 11.
10
Estrogen regulates stemness and senescence of bone marrow stromal cells to prevent osteoporosis via ERβ-SATB2 pathway.雌激素通过 ERβ-SATB2 通路调节骨髓基质细胞的干性和衰老,以预防骨质疏松症。
J Cell Physiol. 2018 May;233(5):4194-4204. doi: 10.1002/jcp.26233. Epub 2017 Nov 16.

引用本文的文献

1
Mechanisms and therapeutic strategies linking mesenchymal stem cells senescence to osteoporosis.将间充质干细胞衰老与骨质疏松症联系起来的机制及治疗策略。
Front Endocrinol (Lausanne). 2025 Jul 21;16:1625806. doi: 10.3389/fendo.2025.1625806. eCollection 2025.
2
Second-Generation Antipsychotics Induce Metabolic Disruption in Adipose Tissue-Derived Mesenchymal Stem Cells Through an aPKC-Dependent Pathway.第二代抗精神病药物通过aPKC依赖性途径诱导脂肪组织来源的间充质干细胞发生代谢紊乱。
Cells. 2024 Dec 17;13(24):2084. doi: 10.3390/cells13242084.
3
Multiomics profiling reveals VDR as a central regulator of mesenchymal stem cell senescence with a known association with osteoporosis after high-fat diet exposure.多组学分析揭示 VDR 是间充质干细胞衰老的中央调节因子,其与高脂肪饮食暴露后骨质疏松症的已知关联。
Int J Oral Sci. 2024 May 22;16(1):41. doi: 10.1038/s41368-024-00309-9.
4
A Mesenchymal stem cell Aging Framework, from Mechanisms to Strategies.间充质干细胞衰老框架:从机制到策略
Stem Cell Rev Rep. 2024 Aug;20(6):1420-1440. doi: 10.1007/s12015-024-10732-4. Epub 2024 May 10.
5
Molecular and Cellular Mechanisms of Osteoporosis.骨质疏松症的分子和细胞机制。
Int J Mol Sci. 2023 Oct 30;24(21):15772. doi: 10.3390/ijms242115772.
6
Mesenchymal Stem Cell Senescence during Aging:From Mechanisms to Rejuvenation Strategies.衰老过程中的间充质干细胞衰老:从机制到年轻化策略
Aging Dis. 2023 Oct 1;14(5):1651-1676. doi: 10.14336/AD.2023.0208.
7
Age Related Osteoporosis: Targeting Cellular Senescence.与年龄相关的骨质疏松症:靶向细胞衰老。
Int J Mol Sci. 2022 Feb 28;23(5):2701. doi: 10.3390/ijms23052701.
8
miR-21 regulates osteogenic and adipogenic differentiation of BMSCs by targeting PTEN.miR-21 通过靶向 PTEN 调节 BMSCs 的成骨和成脂分化。
J Musculoskelet Neuronal Interact. 2021 Dec 1;21(4):568-576.
9
Tumorigenic Aspects of MSC Senescence-Implication in Cancer Development and Therapy.间充质干细胞衰老的致瘤性方面——对癌症发展和治疗的影响
J Pers Med. 2021 Nov 2;11(11):1133. doi: 10.3390/jpm11111133.
10
Apoptosis resistance of senescent cells is an intrinsic barrier for senolysis induced by cardiac glycosides.衰老细胞的凋亡抵抗是心脏糖苷诱导衰老细胞裂解的内在障碍。
Cell Mol Life Sci. 2021 Dec;78(23):7757-7776. doi: 10.1007/s00018-021-03980-x. Epub 2021 Oct 29.

本文引用的文献

1
Muscle-derived miR-34a increases with age in circulating extracellular vesicles and induces senescence of bone marrow stem cells.肌肉来源的miR-34a在循环细胞外囊泡中随年龄增长而增加,并诱导骨髓干细胞衰老。
Aging (Albany NY). 2019 Mar 25;11(6):1791-1803. doi: 10.18632/aging.101874.
2
Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l.通过组蛋白甲基转移酶 Ash1l 对间充质干细胞命运决定的表观遗传控制。
Stem Cells. 2019 Jan;37(1):115-127. doi: 10.1002/stem.2918. Epub 2018 Oct 8.
3
MicroRNA-31a-5p from aging BMSCs links bone formation and resorption in the aged bone marrow microenvironment.衰老骨髓间充质干细胞中的 microRNA-31a-5p 介导衰老骨髓微环境中的成骨与破骨。
Aging Cell. 2018 Aug;17(4):e12794. doi: 10.1111/acel.12794. Epub 2018 Jun 12.
4
GH prevents adipogenic differentiation of mesenchymal stromal stem cells derived from human trabecular bone via canonical Wnt signaling.生长激素通过经典 Wnt 信号通路抑制人眼眶小梁骨来源间充质基质干细胞向脂肪细胞分化。
Bone. 2018 Jul;112:136-144. doi: 10.1016/j.bone.2018.04.014. Epub 2018 Apr 22.
5
Targeting cellular senescence prevents age-related bone loss in mice.靶向细胞衰老可预防小鼠的年龄相关性骨质流失。
Nat Med. 2017 Sep;23(9):1072-1079. doi: 10.1038/nm.4385. Epub 2017 Aug 21.
6
Overexpression of Insulin-Like Growth Factor 1 Enhanced the Osteogenic Capability of Aging Bone Marrow Mesenchymal Stem Cells.胰岛素样生长因子1的过表达增强了衰老骨髓间充质干细胞的成骨能力。
Theranostics. 2017 Apr 10;7(6):1598-1611. doi: 10.7150/thno.16637. eCollection 2017.
7
Identification of Senescent Cells in the Bone Microenvironment.骨微环境中衰老细胞的鉴定
J Bone Miner Res. 2016 Nov;31(11):1920-1929. doi: 10.1002/jbmr.2892. Epub 2016 Oct 24.
8
Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?间充质干细胞的命运抉择:脂肪细胞还是成骨细胞?
Cell Death Differ. 2016 Jul;23(7):1128-39. doi: 10.1038/cdd.2015.168. Epub 2016 Feb 12.
9
Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.长期衰老细胞溶解疗法可缓解老年或动脉粥样硬化小鼠已有的血管舒缩功能障碍。
Aging Cell. 2016 Oct;15(5):973-7. doi: 10.1111/acel.12458. Epub 2016 Aug 5.
10
Targeting senescent cells enhances adipogenesis and metabolic function in old age.靶向衰老细胞可增强老年个体的脂肪生成和代谢功能。
Elife. 2015 Dec 19;4:e12997. doi: 10.7554/eLife.12997.